Academic Handbook Course Descriptors and Programme Specifications
LBIOL62127A Frontier Topics in Bioscience Course Descriptor
Last modified on August 13th, 2024 at 3:32 pm
Course code | LBIOL62127A | Discipline | Bioscience and Chemistry |
UK Credit | 15 | US Credit | |
FHEQ level | 6 | ||
Pre-requisites | None | ||
Co-requisites | None |
Course Overview
This course examines modern advances in bioscience and health, such as omics, biomarkers, biologics, big data, personalised medicine and public health strategies. Learners will perform critical analysis, evaluate and discuss the pros and cons of each topic using a range of scholarly articles. The social and ethical contexts are considered alongside the scientific advances. Learners will use reflective practice to evaluate their own position on ethical dilemmas and the advancement of science.
Learning Outcomes
On successful completion of the course, learners will be able to:
Knowledge and Understanding
K1c | Systematically understand and have detailed knowledge of modern advances in bioscience and health. |
K2c | Conceptually understand laboratory practice that is at the forefront of the discipline. |
K3c | Critically understanding how to use data mining and research methodologies to explore and evaluate new scientific advances. |
Subject Specific Skills
S2c | Critically evaluate scientific advances using creative thinking, data mining and scholarly reviews. |
S3c | Work autonomously to analyse, interpret and robustly evaluate scientific data and communicate ideas. |
Transferable and Professional Skills
T2c | Apply analytical, critical thinking and problem solving to evaluate scholarly literature. |
T3ci | Communicate critical arguments and big-picture thinking to non-specialist audiences. |
T3cii | Display an advanced level of technical proficiency in written English and competence in applying scholarly terminology, so as to be able to apply skills in critical evaluation, analysis and judgement effectively in a diverse range of contexts. |
Teaching and Learning
This is an e-learning course, taught throughout the year.
This course can be offered as a standalone short course.
Teaching and learning strategies for this course will include:
- Online learning
- Online discussion groups
- Online assessment
Course information and supplementary materials will be available on the University’s Virtual Learning Environment (VLE).
Learners are required to attend and participate in all the formal and timetabled sessions for this course. Learners are also expected to manage their self-directed learning and independent study in support of the course.
The course learning and teaching hours will be structured as follows:
- Off-the-job learning and teaching (6 days x 7 hours) = 42 hours
- On-the-job learning (12 days x 7 hours) = 84 hours (e.g. 2 days per week for 6 weeks)
- Private study (4 hours per week) = 24 hours
Total = 150 hours
Workplace assignments (see below) will be completed as part of on-the-job learning.
Assessment
Formative
Learners will be formatively assessed during the course by means of set assignments. These will not count towards the final degree but will provide learners with developmental feedback.
Summative
AE | Assessment Type | Weighting | Online submission | Duration | Length |
1 | Portfolio (work-based exercises) | 50% | Yes | Requiring on average 20 – 25 hours to complete | – |
2 | Written Assignment (case study based) | 50% | Yes | Requiring on average 20 – 25 hours to complete | – |
Feedback
Learners will receive formal feedback in a variety of ways: written (via email or VLE correspondence) and indirectly through online discussion groups. Learners will also attend a formal meeting with their Success Manager (and for apprentices, including their Line Manager). These bi or tri-partite reviews will monitor and evaluate the learner’s progress.
Feedback is provided on summatively assessed assignments and through generic internal examiners’ reports, both of which are posted on the VLE.
Indicative Reading
Note: Comprehensive and current reading lists for courses are produced annually in the Course Syllabus or other documentation provided to learners; the indicative reading list provided below is used as part of the approval/modification process only.
Books
- Turnpenny, P. D., Ellard, S., & Cleaver, R. (2021). Emery’s Elements of Medical Genetics and Genomics (Sixteenth edition.). Philadelphia, PA : Elsevier 2021
- O’Donnell, J. J. (2020). Drug Discovery and Development. Boca Raton, FL : CRC Press, Taylor & Francis Group 2020
Journals
Learners are encouraged to read material from relevant journals on frontier topics in bioscience as directed by their course leader, such as:
- Allen, P. G. (2016). New frontiers in bioscience. Science (American Association for the Advancement of Science), 352(6281), 11–11. https://doi.org/10.1126/science.aaf7711
Electronic Resources
Learners are encouraged to consult relevant websites on frontier topics in bioscience.
Indicative Topics
- Advances in genetics
- Advanced statistical tools and methodologies
- Advances in drug discovery and therapeutics
Version History
Title: NCHNAP6135 Frontier Topics in Bioscience Course Descriptor
Approved by: Academic Board Location: Academic Handbook/Programme specifications and Handbooks/ Undergraduate Apprenticeship Programmes/BSc (Hons) Bioscience with Digital Technologies Programme Specification/Course Descriptors |
|||||
Version number | Date approved | Date published | Owner | Proposed next review date | Modification (As per AQF4) & category number |
4.0 | July 2024 | July 2024 | Dr Helen Dawe | July 2028 | Category 1: Corrections/clarifications to documents which do not change approved content or learning outcomes
Category 3: New course code |
3.0 | October 2022 | January 2023 | Scott Wildman | September 2026 | Category 1: Corrections/clarifications to documents which do not change approved content or learning outcomes
Category 3: Changes to Learning Outcomes |
2.0 | January 2022 | April 2022 | Scott Wildman | September 2026 | Category 3: Changes to Learning Outcomes |
1.0 | September 2021 | September 2021 | Scott Wildman | September 2026 |